In conclusion, our results uncovered a role of LIGHT in poly(I:C)-induced acute hepatitis, which may lead to new therapeutic strategies targeting this molecule in treating liver diseases and shed new insights into the pathogenesis for TLR3-triggered inflammation diseases. This evidence concerns the gene TNFSF14 and Acute hepatitis.